Janney Montgomery Scott’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.55M | Buy |
27,427
+4,913
| +22% | +$286K | ﹤0.01% | 1413 |
|
|
2025
Q4 | $1.34M | Buy |
22,514
+11,965
| +113% | +$651K | ﹤0.01% | 1568 |
|
|
2025
Q3 | $571K | Buy |
10,549
+14
| +0.1% | +$801 | ﹤0.01% | 2060 |
|
|
2025
Q2 | $579K | Sell |
10,535
-1,481
| -12% | -$87.2K | ﹤0.01% | 1925 |
|
|
2025
Q1 | $849K | Buy |
12,016
+4,345
| +57% | +$292K | ﹤0.01% | 1649 |
|
|
2024
Q4 | $504K | Sell |
7,671
-4,029
| -34% | -$270K | ﹤0.01% | 1993 |
|
|
2024
Q3 | $822K | Buy |
11,700
+5,911
| +102% | +$494K | ﹤0.01% | 1635 |
|
|
2024
Q2 | $477K | Sell |
5,789
-2,633
| -31% | -$219K | ﹤0.01% | 1925 |
|
|
2024
Q1 | $736K | Sell |
8,422
-266
| -3% | -$23.8K | ﹤0.01% | 1704 |
|
|
2023
Q4 | $837K | Sell |
8,688
-280
| -3% | -$24.8K | ﹤0.01% | 1551 |
|
|
2023
Q3 | $793K | Sell |
8,968
-57
| -0.6% | -$5.07K | ﹤0.01% | 1463 |
|
|
2023
Q2 | $782K | Sell |
9,025
-133
| -1% | -$12.5K | ﹤0.01% | 1563 |
|
|
2023
Q1 | $891K | Sell |
9,158
-1,451
| -14% | -$150K | ﹤0.01% | 1386 |
|
|
2022
Q4 | $1.1M | Sell |
10,609
-383
| -3% | -$36K | ﹤0.01% | 1316 |
|
|
2022
Q3 | $932K | Buy |
10,992
+1,603
| +17% | +$143K | ﹤0.01% | 1347 |
|
|
2022
Q2 | $780K | Sell |
9,389
-3,354
| -26% | -$267K | ﹤0.01% | 1368 |
|
|
2022
Q1 | $982K | Sell |
12,743
-22,197
| -64% | -$1.86M | ﹤0.01% | 1258 |
|
|
2021
Q4 | $3.09M | Sell |
34,940
-853
| -2% | -$70.4K | 0.01% | 794 |
|
|
2021
Q3 | $2.77M | Buy |
35,793
+1,641
| +5% | +$129K | 0.01% | 806 |
|
|
2021
Q2 | $2.85M | Buy |
34,152
+9,098
| +36% | +$721K | 0.01% | 793 |
|
|
2021
Q1 | $1.89M | Buy |
25,054
+1,175
| +5% | +$96K | 0.01% | 914 |
|
|
2020
Q4 | $2.09M | Sell |
23,879
-6,682
| -22% | -$530K | 0.01% | 852 |
|
|
2020
Q3 | $2.33M | Sell |
30,561
-32,427
| -51% | -$3.28M | 0.01% | 754 |
|
|
2020
Q2 | $7.77M | Buy |
62,988
+43,750
| +227% | +$4.35M | 0.05% | 331 |
|
|
2020
Q1 | $1.63M | Buy |
19,238
+1,751
| +10% | +$151K | 0.01% | 768 |
|
|
2019
Q4 | $1.48M | Sell |
17,487
-1,371
| -7% | -$104K | 0.01% | 905 |
|
|
2019
Q3 | $1.27M | Buy |
18,858
+7,061
| +60% | +$544K | 0.01% | 930 |
|
|
2019
Q2 | $1.01M | Buy |
11,797
+4,857
| +70% | +$415K | 0.01% | 1044 |
|
|
2019
Q1 | $616K | Buy |
6,940
+268
| +4% | +$24.8K | 0.01% | 1274 |
|
|
2018
Q4 | $568K | Sell |
6,672
-1,823
| -21% | -$173K | 0.01% | 1221 |
|
|
2018
Q3 | $824K | Sell |
8,495
-800
| -9% | -$79.9K | 0.01% | 1151 |
|
|
2018
Q2 | $876K | Sell |
9,295
-1,450
| -13% | -$127K | 0.01% | 1052 |
|
|
2018
Q1 | $871K | Buy |
10,745
+1,264
| +13% | +$108K | 0.01% | 1031 |
|
|
2017
Q4 | $845K | Sell |
9,481
-774
| -8% | -$67.3K | 0.01% | 1035 |
|
|
2017
Q3 | $954K | Sell |
10,255
-1,310
| -11% | -$116K | 0.01% | 956 |
|
|
2017
Q2 | $1.05M | Sell |
11,565
-771
| -6% | -$70.1K | 0.01% | 848 |
|
|
2017
Q1 | $1.08M | Buy |
12,336
+550
| +5% | +$48.9K | 0.01% | 807 |
|
|
2016
Q4 | $976K | Sell |
11,786
-1,795
| -13% | -$154K | 0.01% | 784 |
|
|
2016
Q3 | $1.26M | Buy |
+13,581
| New | +$1.28M | 0.02% | 574 |
|
|
2016
Q2 | – | Sell |
-7,365
| Closed | -$607K | – | 723 |
|
|
2016
Q1 | $607K | Sell |
7,365
-1,616
| -18% | -$131K | 0.02% | 698 |
|
|
2015
Q4 | $941K | Sell |
8,981
-1,904
| -17% | -$199K | 0.02% | 567 |
|
|
2015
Q3 | $1.15M | Sell |
10,885
-920
| -8% | -$123K | 0.03% | 492 |
|
|
2015
Q2 | $1.61M | Buy |
11,805
+846
| +8% | +$105K | 0.03% | 573 |
|
|
2015
Q1 | $1.37M | Buy |
10,959
+2,076
| +23% | +$220K | 0.03% | 724 |
|
|
2014
Q4 | $803K | Buy |
8,883
+499
| +6% | +$41.5K | 0.02% | 978 |
|
|
2014
Q3 | $605K | Buy |
8,384
+800
| +11% | +$52.6K | 0.01% | 1139 |
|
|
2014
Q2 | $472K | Buy |
+7,584
| New | +$458K | 0.01% | 1279 |
|
Other funds holding BMRN
VCM
VPM
Janney Montgomery Scott's BMRN Position: Q1 2026 in Review
Janney Montgomery Scott increased its BioMarin Pharmaceuticals (BMRN) stake by 22% in Q1 2026, buying an estimated $286K and bringing the position to 27,427 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1413.
Janney Montgomery Scott first reported a position in BMRN in Q2 2014 and has held it in 47 quarters since. The position peaked at $7.77M in Q2 2020. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Janney Montgomery Scott held 27,427 shares of BioMarin Pharmaceuticals worth $1.55M as of Q1 2026.
- Janney Montgomery Scott bought 4,913 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $286K.
- BioMarin Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1413 holding.
- Janney Montgomery Scott first reported a position in BioMarin Pharmaceuticals in Q2 2014 and has held it in 47 quarters since.
- Janney Montgomery Scott's BioMarin Pharmaceuticals position peaked at $7.77M in Q2 2020.
- 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.